comparemela.com

Latest Breaking News On - Neurexis therapeutics inc - Page 1 : comparemela.com

Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis Therapeutics to Evaluate Neuroprotective Therapeutic in Stroke Preclinical Assessment Network (SPAN)

AURORA, CO (PRWEB) April 19, 2023 Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 in funding from a Direct-to-Phase II Small

Olivia asfahaUlli bayerNeurexis therapeutics incorporatedIi small business innovation researchUniversity of colorado anschutz medical campusStroke preclinical assessment networkNational institutes of healthNeurexis therapeutics incNational institute of neurological disordersCo principal investigatorBusiness innovation researchNational instituteNeurological disordersNational institutesColorado anschutz medical campusNeurexis therapeutics

Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic

Aurora, CO (PRWEB) October 14, 2021 Neurexis Therapeutics, Incorporated, announces it has been awarded a $496,145 grant from the National Institute of

Michael artingerUlli bayerNeurexis therapeutics incInvestor networkUniversity of colorado anschutz medical campusNeurexis therapeutics incorporatedTechnology venture developmentNational institute of neurological disordersNational instituteNeurological disordersGlobal cerebral ischemiaVenture developmentColorado anschutz medical campusNeurexis therapeuticsPress release

vimarsana © 2020. All Rights Reserved.